A treatment strategy combining intraperitoneal paclitaxel with systemic chemotherapy has shown encouraging survival outcomes ...
In clinical practice, only a few risk factors remain that can be modified based on the decisions of patients and their physicians. The surgical decision making and chemotherapy administration choices, ...
Hyperthermic intraperitoneal chemotherapy (secondary cytoreduction CRS + HIPEC) for recurrent epithelial ovarian cancer (EOC): Indian experience. This is an ASCO Meeting Abstract from the 2015 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results